Divi's Laboratories Limited carries what we call a hope premium: an average business trading at an ambitious price. One caution: reported profits have recently run ahead of actual cash, which we track closely.
The price is expensive. You pay 317.8× its owner earnings: the cash an owner could take out each year, which is in the historically expensive zone. At today's price, the market is assuming roughly 45% yearly growth; analysts expect 19%. The market is pricing in far more than analysts expect: heroic expectations.
The trajectory is solid and the balance sheet is sturdy. The company scores 13/20 on our value-creation score: creating some value. Analyst sentiment is cautious.
What to watch: Reported profits have run ahead of actual cash for several periods. As always: this describes the company's numbers; it is not a recommendation.
360° rank · history
1007550250
Jan 202353
30
2023202420252026
All-time high
63
Feb 2024
All-time low
15
Jul 2023
Average rank
35
across all years
Detailed & Historical Ranks
Deep dive into 15 detailed ranks and 3 years of history.
Current202520242023
Price/Sales
1
1
5
3
Price/Earnings
7
5
12
22
Price/Book
10
14
28
20
Dividend Yield
47
34
42
34
Value (overall)
7
5
19
13
Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.